Effect of Probiotic Supplementation in Preventing Necrotizing Enterocolitis Sepsis and Mortality Among Preterm and Very Low Birth Weight Infants: A Systematic Review and Meta-Analysis
Abstract
Preterm and very low birth weight (VLBW) infants are highly vulnerable to gastrointestinal and systemic complications due to immature gut barriers, dysbiosis, and underdeveloped immunity, with necrotizing enterocolitis (NEC) and late-onset sepsis contributing significantly to morbidity and mortality. Probiotic supplementation has been proposed as a strategy to restore gut microbial balance, enhance gastrointestinal maturation, and reduce disease risk. This study systematically reviews the impact of probiotics on NEC, sepsis, mortality, feeding tolerance, hospitalization, and related physiological outcomes in preterm and VLBW infants. Studies were identified through databases in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, including those that examined probiotic interventions in preterm or VLBW populations. Primary outcomes assessed were NEC, sepsis, and mortality, while secondary outcomes included feeding tolerance, hospital stay, and inflammatory or metabolic markers. Data were extracted and synthesized narratively to evaluate clinical trends and strain-specific efficacy. Findings showed that multi-strain probiotic supplementation consistently reduced NEC incidence, improved feeding tolerance, accelerated full oral feeding, and shortened hospitalization. Selected probiotics also lowered C-reactive protein and total serum bilirubin, suggesting systemic anti-inflammatory and metabolic benefits, whereas single-strain…
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
- A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
- Bioaccessibility and bioavailability of phenolic compounds
- The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development
- Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery
- Effects of the Mediterranean Diet on the Components of Metabolic Syndrome Concerning the Cardiometabolic Risk
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.